ABOUT US / THE CONSORTIUM

Many perspectives.
One shared purpose.

LiT-Met brings together clinical expertise, artificial intelligence and patient perspectives to help improve care for people with colorectal cancer that has spread to the liver.

CONNECTED BY A COMMON QUESTION

How can we make the right treatment clearer?

For people with colorectal liver metastases, choosing a treatment can be complex. LiT-Met is investigating where liver transplantation may offer a benefit compared with complex liver resection, and how better evidence can support individual decisions.

Led by the University of Bologna, our European consortium connects hospitals, universities, technology specialists and organisations representing patients and healthcare professionals.

Together, we look beyond clinical outcomes alone — considering quality of life, fair access and the resources needed to deliver care.

OUR WAY OF WORKING

Expertise that works together.

01

Clinically grounded

Clinical teams contribute real-world experience, harmonised data and prospective research across a network of European centres.

02

Connected by evidence

Researchers combine clinical information, imaging and biological insights to explore more personalised approaches to treatment.

03

Centred on people

Patient perspectives help us understand what matters in everyday life, alongside survival, recovery and long-term health.

THE PEOPLE AND ORGANISATIONS BEHIND LiT-Met

21 organisations. A European collaboration.

Complementary expertise, shared ambition. Meet the organisations contributing to LiT-Met.

Better questions. Stronger collaboration.

Interested in our research, dissemination activities or opportunities to connect with the consortium?